Blood-based biomarker discovery points to early-stage Alzheimer’s test
New research is suggesting high levels of a certain blood-based biomarker may serve as an early warning sign of Alzheimer’s disease, two years before symptoms develop. The preliminary study has yet to be verified in larger cohorts of patients. Source of Article